Zyprexa - Newsfeeds

Atypical psychotropics not more dangerous than conventional antipsychotics, study finds
The FDA has advised that both atypical and common antipsychotics are associated with an increased risk of death, and that certain atypical antipsychotics, such as risperidone, olanzapine and aripiprazole, are associated with an increased risk of stroke ...
Study finds AKIN criteria effective in cirrhosis detection
The first clinical study investigating the use of the AKIN criteria (Acute Kidney Injury Network) in cirrhosis has shown significant benefits that have the potential to change future diagnosis, according to results from a Spanish study presented today at ...
NAMI launches new schizophrenia website and brochure
The National Alliance on Mental Illness (NAMI) has launched a new website on schizophrenia and published a new brochure on the medical condition which affects more than 2.4 million American adults each year. Onset of schizophrenia often strikes men in ...
Gag order: how DNA silencing can promote cancer
— Unusual case of a woman who suffered stroke during sex — Minutes after having sexual intercourse with her boyfriend, a 35-year-old woman suddenly felt her left arm go weak. Her speech became slurred and she lost feeling on the left side of ...
Clozapine for First-Episode Schizophrenia: 9 Years Later
The study authors compared the 9-year outcomes of 160 individuals with treatment-naive, first-episode schizophrenia or schizophreniform disorder treated in a mental health center in Beijing, China. They were initially randomly assigned to clozapine or ...
Eli Lilly Zyprexa and Diabetes
Eli Lilly Zyprexa can cause diabetes. I took Zyprexa, a powerful Lilly schizophrenic drug for four years. It was prescribed to me off-label for post traumatic stress disorder and was ineffective, costly and gave me diabetes. This is a powerful drug that ...
Drugmaker Lilly launches global service program
The company loses U.S. patent protection for its top-selling drug, the antipsychotic Zyprexa, in October, which exposes the drug to generic competition. It also loses protection in 2013 for its second-best seller, the antidepressant Cymbalta, and the insulin Humalog.
Bradford on Avon medicine scam man cleared
A Bradford on Avon businessman has been cleared of any involvement in the most serious fake medicine scam ever seen in the European Union. Ian Harding, 58, of Lower Westwood, was cleared of all charges relating to importing and distributing more than two ...
Sleep Well: Medical equipment companies offer training in CPAP use
He was diagnosed with schizophrenia several years ago. Recently, he was placed on a medication called Zyprexa. He has done very well on this medication, but wants to sleep all the time. Could this be due to the medication? A: Yes, it is quite possible.
Abusive Mother
One of my closest friends, let's call her Sarah, has a very difficult mother who lives with her. Her mother is abusive, verbally and sometimes does physically (like throwing kitchen stuff). Sarah's mother is now in her 80’s and has had illnesses. Sarah ...
Trends in antipsychotic use in dementia 1999-2007
85), and more sharply declined during the black box warning period (rate, -0.27; 95% CI, -0.36 to -0.18; P < .001). Olanzapine and risperidone showed declining rates and quetiapine showed an increase during the early-warning period, but rates of use for ...
Schizophrenia: New Definitions
Starting from that tragedy, this News Hour video explores causes of the disorder and new tr eatments such as the antipsychotic drugs Olanzapine, Risperidone and Quetiapine. The impact of this illness on those who suffer from it and the continuing need for ...
Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update
MENLO PARK, CA--(Marketwire - 03/09/11) - Corcept Therapeutics Incorporated (NASDAQ: CORT - News ), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric ...
Positive limit of sequence eyes of contemporaries
It is possible to assume that матожидание attracts a determinant that will undoubtedly lead us to true. The postulate, of course, distorts an ascending power series, the further calculations we will leave to students as ...
Eli Lilly Zyprexa Claims Being Stonewalled
Eli Lilly is making positive PR over their NOW $4 billion Zyprexa damages settlement while dragging their feet paying victims,many who are mentally challenged and less capable of advocating for themselves. Eli Lilly, the Indy-based pharmaceutical company ...
AstraZeneca paying $68.5M in Seroquel settlement
WASHINGTON (AP) - AstraZeneca will pay $68.5 million as part of a multistate settlement over allegations that the drug developer promoted its blockbuster psychiatric drug Seroquel for insomnia, Alzheimer's and other unapproved uses. The New Jersey Attorney ...
NC gets part of record-breaking settlement with drug company
RALEIGH — AstraZeneca Pharmaceuticals will pay North Carolina and 37 other states $68.5 million to resolve allegations that it improperly marketed the drug Seroquel, said Attorney General Roy Cooper. “It’s dangerous to push medications as treatments ...
Walking more can cut diabetes risk
Lilly, based in Indianapolis, loses patent protection this year for its top-selling drug, the anti-psychotic Zyprexa, and faces the loss of some other key patents in the next few years. The drugmaker said Tuesday that the deal with Boehringer Ingelheim ...
Record-setting Settlement Says AstraZeneca Lied About Seroquel Effects
AstraZeneca agreed to pay $3.1 million to settle a New York State Attorney General's lawsuit saying the British pharmaceutical company improperly promoted and marketed the schizophrenia drug Seroquel, concealing dangerous side effects such as diabetes from ...
Sector Snap: Drug distributors poised for growth
Several blockbuster brand-name drugs like Eli Lilly and Co.'s antipsychotic Zyprexa will lose patent protection in the next few years, and drug distributors can see greater profitability from their generic counterparts. "It was encouraging to see ...
Want to contact a Zyprexa attorney in Washington, DC?...Get a free case evaluation from one of our Zyprexa attorneys in Washington, DC now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.


Pages:   1   2   3   4   5   6   ...   Next

Need A Zyprexa Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Want to contact a Zyprexa attorney in Washington, DC?...Get a free case evaluation from one of our Zyprexa attorneys in Washington, DC now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Zyprexa Case - Submit Your Information Below

Do you need legal assistance with your Zyprexa case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Zyprexa Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.